SEARCH

SEARCH BY CITATION

References

  • 1
    Braun MY, McCormack A, Webb G, Batchelor JR. Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1993; 55: 177182.
  • 2
    Tallquist MD, Pease LR. Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule. J Immunol 1995; 155: 24192426.
  • 3
    Shirwan H, Barwari L, Cramer DV. Rejection of cardiac allografts by T cells expressing a restricted repertoire of T-cell receptor Vb genes. Immunology 1997; 90: 572578.
  • 4
    Benichou G, Takizawa PA, Olson CA, McMillan M, Sercarz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305308.
  • 5
    Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 15211529.
  • 6
    Shirwan H, Leamer M, Makowka L, Cramer DV. Peptides derived from a-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allografts rejection. Transplantation 1995; 59: 401410.
  • 7
    Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition: recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572576.
  • 8
    Braun MY, McCormack A, Webb G, Batchelor JR. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection. Transplant Proc 1993; 25: 863864.
  • 9
    Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: an overview. Transplant Immunol 1993; 1: 327.
  • 10
    Shirwan H. Chronic allograft rejection. do the Th2 cells preferentially induced by indirect recognition play a dominant role? Transplantation 1999; 68: 715726.
  • 11
    Bradley JA, Mowat AM, Bolton EM. Processed MHC class I alloantigen as the stimulus for CD4+ T cell-dependent antibody-mediated graft rejection. Immunol Today 1992; 13: 434438.
  • 12
    Mhoyan A, Cramer DV, Baquerizo A, Shirwan H. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides: 1. Correlation of graft survival with anti-donor IgG antibody subclasses. Transplantation 1997; 64: 16651670.
  • 13
    Shirwan H, Mhoyan A, Leamer M, Wang C, Cramer DV. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance. Transplant Proc 1997; 29: 11341135.
  • 14
    Shirwan H, Wang C, Barwari L, Cramer DV. Recipient-donor microchimerism is not a prerequisite for the maintenance of allograft tolerance. Transplant Proc 1997; 29: 11821183.
  • 15
    Shirwan H, Barwari L, Sattar-Khan N. Predominant expression of Th2 and altered expression of Th1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I MHC peptides. Transplantation 1998; 66: 18021809.
  • 16
    Shirwan H, Wu GD, Barwari L, Liu A, Cramer DV. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism. Transplantation 1997; 64: 16711676.
  • 17
    Sayegh MH, Perico N, Gallon L et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125132.
  • 18
    Odorico JS, Posselt AM, Naji A, Markmann JF, Barker CF. Promotion of rat cardiac allograft survival by intrathymic inoculation of donor splenocytes. Transplantation 1993; 55: 11041107.
  • 19
    Ohzato H, Monaco AP. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Transplantation 1992; 54: 10901095.
  • 20
    Chen W, Sayegh MH, Khoury SJ. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. J Immunol 1998; 160: 15041508.
  • 21
    Oluwole SF, Jin MX, Chowdhury NC, Engelstad K, Ohajekwe OA, James T. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Cell Immunol 1995; 162: 3341.
  • 22
    Binder J, Graser E, Hancock WW et al. Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. Transplantation 1995; 60: 15161524.
  • 23
    Cramer DV, Shirwan H. The importance of humoral immune responses in chronic rejection. Transplant Rev 1998; 12: 166176.
  • 24
    Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 13921396.
  • 25
    Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 1999; 155: 19291939.
  • 26
    Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25 (+) CD4 (+) regulatory T cells by oral antigen administration. J Immunol 2001; 167: 42454253.
  • 27
    Itoh M, Takahashi T, Sakaguchi N et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 53175326.
  • 28
    Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells. their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 1832.
  • 29
    Qin S, Cobbold SP, Pope H et al. ‘Infectious’ transplantation tolerance. Science 1993; 259: 974977.
  • 30
    Yin D, Fathman CG. CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995; 154: 63396345.
  • 31
    Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Cell Transplant 1999; 8: 375381.
  • 32
    Adams DH, Tilney NL, Collins JJJ, Karnovsky MJ. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model. Transplantation 1992; 53: 11151119.
  • 33
    Reemtsen BL, Kato H, Wang TS, Busuttil RW, Kupiec-Weglinski JW, Goss JA. Intrathymic immunomodulation and the ‘infectious’ tolerance pathway in allograft recipients. J Surg Res 1999; 84: 17.
  • 34
    Goss JA, Nakafusa Y, Roland CR, Hickey WF, Flye MW. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. J Immunol 1994; 153: 38903898.
  • 35
    Markmann JF, Bassiri H, Desai NM, Kim JI, Odorico JS, Barker CF. Donor antigen-specific T lymphocyte deletion after intrathymic inoculation. Transplant Proc 1993; 25: 305306.
  • 36
    Chowdhury NC, Murphy B, Sayegh MH et al. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation 1996; 62: 18781882.
  • 37
    Sayegh MH, Perico N, Imberti O, Hancock WW, Carpenter CB, Remuzzi G. Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. Transplantation 1993; 56: 461465.
  • 38
    Hillebrands JL, Raue HP, Klatter FA et al. Intrathymic immune modulation prevents acute rejection but not the development of graft arteriosclerosis (chronic rejection). Transplantation 2001; 71: 914924.
  • 39
    Goss JA, Nakafusa YYuS, Flye MW. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts. Transplantation 1993; 56: 166173.
  • 40
    Oluwole SF, Chowdhury NC, Fawwaz RA. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells. Transplantation 1993; 55: 13891395.
  • 41
    Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264: 15871589.
  • 42
    Khoury SJ, Gallon L, Chen W et al. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: Thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995; 182: 357366
  • 43
    Oluwole OO, DePaz HA, Gopinathan R et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells. Diabetes 2001; 50: 15461552.
  • 44
    Agus DB, Surh CD, Sprent J. Re-entry of T cells to the adult thymus is restricted to activated T cells. J Exp Med 1991; 173: 10391046.
  • 45
    Davies JD, Leong LYW, Mellor A, Cobbold S, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 36023607.